Zymeworks To Present Preclinical Data On T Cell Engager And Antibody-Drug Conjugate Platforms In Six Posters At AACR Annual Meeting
Novel trispecific T cell engager, ZW209, demonstrates potent preclinical efficacy against DLL3-expressing tumors and an encouraging safety profile ...
Elevation Oncology To Present Preclinical Data For EO-1022 At The American Association For Cancer Research (AACR) Annual Meeting 2025
Abstract accepted for late-breaking poster presentation – -- EO-1022 is a potentially differentiated HER3 ADC being developed for the treatment of solid ...
ADC Therapeutics Announces Abstracts Accepted for Presentation at the American Association for Cancer Research Annual Meeting 2025
ADC Therapeutics SA (NYSE: ADCT), a commercial-stage global leader and pioneer in the field of antibody drug conjugates (ADCs ...